Archive | News

Washington Business Journal: Maryland Biotech Outlines Path for Blood Cancer Drug, Including in China

logo-glyco

Rockville biotech GlycoMimetics Inc. has entered into a license agreement worth $189 million or more with a West Coast company. The deal gives cancer therapy biopharma Apollomics Inc. of Foster City, California exclusive rights to develop and commercialize GlycoMimetics’ blood cancer drug in greater China, which encompasses mainland China, Hong Kong, Taiwan and Macau, the […]

Comments Off on Washington Business Journal: Maryland Biotech Outlines Path for Blood Cancer Drug, Including in China Continue Reading →

Technical.ly Baltimore: MTC's Martin Rosendale, UM BioPark's James Hughes and Others Share Their Thoughts on Baltimore's Imagined Future

TechBmore2-1180x600

Imagined futures: Baltimore tech and biz leaders tell us what they envision for the next decade The year is winding down, which offers time to pause and look back at how we were moving, reading, hiring and exiting in 2019. But in this case, it’s not just about one year: The coming calendar turnover marks […]

Comments Off on Technical.ly Baltimore: MTC's Martin Rosendale, UM BioPark's James Hughes and Others Share Their Thoughts on Baltimore's Imagined Future Continue Reading →

MaxCyte Appoints New Executive Vice President, Business Development for CARMA™ Cellular Therapies and Provides Clinical Trial Update

Shruti A 2X2 Final Maxcyte Portrait Dec 2019 DSC_6560 Coyle Studios

– Shrut Abbato will lead development of new partnerships for the Company’s CARMA platform programs – Phase I trial of lead CARMA candidate MCY-M11 remains on-track with the dosing of the third cohort of patents underway and no dose-limitng toxicites or related serious adverse events observed Gaithersburg, Maryland – DECEMBER 19, 2019: MaxCyte, the global clinical-stage […]

Comments Off on MaxCyte Appoints New Executive Vice President, Business Development for CARMA™ Cellular Therapies and Provides Clinical Trial Update Continue Reading →

Indalo Therapeutics Appoints Healthcare Industry Veteran and Serial Entrepreneur Michael Heffernan as Board Chair

MHeffernan_Headshot

Cambridge, MA, December 17, 2019 – Indalo Therapeutics, a biopharmaceutical company discovering and developing integrin antagonists for patients suffering from serious fibrotic diseases such as idiopathic pulmonary fibrosis (IPF) and nonalcoholic steatohepatitis (NASH), today announced that Michael Heffernan has joined the Board of Directors as Chairman. “Indalo’s unique approach to treating fibrosis, combined with a highly […]

Comments Off on Indalo Therapeutics Appoints Healthcare Industry Veteran and Serial Entrepreneur Michael Heffernan as Board Chair Continue Reading →

BioBuzz: Cartesian Therapeutics CEO Dr. Murat Kalayoglu Participates in "CEO Talk" Panel

Murat

After Leading a Dozen Startups Here is What Four Biotech Founders Had to Share About Their Success In the heart of Montgomery County, Maryland’s premier biotech district there is a 42,000 SF facility with 17,000 SF vacant lab/office suite located at 9900 Medical Center Drive. The newly delivered and available lab space was designed to foster collaboration […]

Comments Off on BioBuzz: Cartesian Therapeutics CEO Dr. Murat Kalayoglu Participates in "CEO Talk" Panel Continue Reading →

Technical.ly Baltimore: UMB Licenses Technology to Y Combinator-backed Biotech Startup

Ritu_headshot_2019-e1575410514124

A biotech startup that’s backed by Silicon Valley’s well-known Y Combinator accelerator has ties to Baltimore: GEn1E Lifesciences is working to commercialize a treatment for inflammatory and age-related diseases that was developed at the University of Maryland, Baltimore, and is partnering with a Baltimore-based startup that also grew out of UMB collaboration. On Tuesday, UMB said it granted GEn1E Lifesciences the […]

Comments Off on Technical.ly Baltimore: UMB Licenses Technology to Y Combinator-backed Biotech Startup Continue Reading →

BioBuzz: For 20 Years This Company Has Helped to Shape the Field of Cell Therapy

Maxcyte logo square

How MaxCyte Has Evolved to Become Leading Technology Provider for Cell Engineering and Leveraged Its Flow Electroporation® Technology and Know-How to Launch Its Own Robust CAR Pipeline  MaxCyte, located in Gaithersburg, Maryland, is a unique biotech company that is a key anchor of the robust and growing Maryland cell and gene therapy industry. Founded in 1999, […]

Comments Off on BioBuzz: For 20 Years This Company Has Helped to Shape the Field of Cell Therapy Continue Reading →

Technical.ly Baltimore: Illumina Opens Training Center at University of Maryland BioPark

UMBioPark-Twitter-Profile-Image

The San Diego genomics leader is expecting the facility to host hundreds of customers and employees each year. Illumina’s first East Coast location is officially open in Baltimore. On Tuesday, the San Diego-based genomics leader celebrated the grand opening of its new facility at the University of Maryland BioPark, the 14-acre research and technology park located to […]

Comments Off on Technical.ly Baltimore: Illumina Opens Training Center at University of Maryland BioPark Continue Reading →

Indalo Therapeutics Initiates Dosing in IPF Patients with Lead Antifibrotic Drug Candidate IDL-2965

Indalo

Key milestone reached in adaptive Phase 1/1b clinical trial that began in April 2019 Cambridge, MA, October 21, 2019 – Indalo Therapeutics, a biopharmaceutical company discovering and developing integrin antagonists for patients suffering from serious fibrotic diseases such as idiopathic pulmonary fibrosis (IPF) and nonalcoholic steatohepatitis (NASH), today announced that the first IPF patient has been […]

Comments Off on Indalo Therapeutics Initiates Dosing in IPF Patients with Lead Antifibrotic Drug Candidate IDL-2965 Continue Reading →

CoapTech LLC Awarded $1.2M Grant from National Institutes of Health to Support Clinical Evaluation and Training for Novel PUMA-G Device

coaptech logo

BALTIMORE, Md., Oct. 21, 2019 (GLOBE NEWSWIRE) — CoapTech LLC announced today that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) within the National Institutes of Health (NIH) awarded the company a two-year, $1.2M R44 Small Business Innovation Research (SBIR) Phase II grant on August 29, 2019. This builds on a $225,000 Phase […]

Comments Off on CoapTech LLC Awarded $1.2M Grant from National Institutes of Health to Support Clinical Evaluation and Training for Novel PUMA-G Device Continue Reading →